P53 in chronic myelogenous leukemia: Study of mechanisms of differential expression

Journal of Experimental Medicine

Volumn 167, Issue 3, 1988, Pages 873-886

  Lubbert M ^a   Miller, C W ^a   Crawford, L ^b   Koeffler, H P ^a  

^a UCLA MEDICAL CENTER   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOPROTEIN; RADIOISOTOPE;

BIOLOGICAL MODEL; BONE MARROW CELL; CELL CULTURE; CHRONIC MYELOID LEUKEMIA; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; LYMPHOID CELL; PROTEIN SYNTHESIS; SOUTHERN BLOTTING;

BLAST CRISIS; DNA, NEOPLASM; GENE EXPRESSION REGULATION; HUMAN; HYBRID CELLS; LEUKEMIA, MYELOID; METHYLATION; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN P53; RECOMBINANT FUSION PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0023928021     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.167.3.873     Document Type: Article

References (49)

1. Milner, J., and S. Milner. 1981. SV40-53K antigen: a possible role for 53K in normal cells. Virology. 112:785.
2. Reich, N., and A. J. Levine. 1984. Growth regulation of a cellular tumor antigen, n p53, in nontransformed cells. Nature (Lond.). 308:199.
3. Mercer, W. E., D. Nelson, A. B. DeLeo, L.J. Old, and R. Baserga. 1982. Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. Proc. Natl. Acad. Sci. USA. 79:6309.
4. Parada, L. F., H. Land, R. A Weinberg, D. Wolf, and V. Rotter. 1984. Cooperation between genes encoding p53 tumor antigen and ras in cellular transformation. Nature o (Lond.). 312:649.
5. Eliyahu, D., A. Raz, P. Gruss, D. Givol, and M. Oren. 1984. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature (Lond.). 312:646.
6. Jenkins, J. R., K. Rudge, and G. A. Currie. 1984. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature (Lond.). 312:651.
7. Koeffler, H. P., C. Miller, M. A. Nicolson, J. Ranyard, and R. A. Bosselman. 1986. Increased expression of p53 protein in human leukemia cells. Proc. Natl. Acad. Sci. USA. 83:4035.
8. Prokocimer, M., M. Shaklai, H. Ben Bassat, D. Wolf, N. Goldfmger, and V. Rotter. 1986. Expression of p53 in human leukemia and lymphoma. Blood. 68:113.
9. Smith, L. J., E. A. McCulloch, and S. Benchimol. 1986. Expression of the p53 oncogene in acute myeloblastic leukemia. J. Exp. Med. 164:751.
10. Wolf, D., and V. Rotter. 1985. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc. Natl. Acad. Sci. USA. 82:790.
11. Wolf, D., and V. Rotter. 1984. Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences. Mol. Cell. Biol. 4:1402.
12. Mowat, M., A. Cheng, N. Kimura, A. Bernstein, and S. Benchimol. 1985. Rearrangements of the cellular p53 gene in erythroleukemic cells transformed by Friend virus. Nature (Lond.). 314:633.
13. Miller, C. W., and H. P. Koeffler. 1987. The p53 gene is frequently rearranged in human osteogenic sarcoma. Clin. Res. 35:630a. (Abstr.)
14. Koeffler, H. P., and D. W. Golde. 1981. Chronic myelogenous leukemia. New concepts. N. Engl. J. Med. 304:1201, 1269.
15. Lozzio, C. B., and B. B. Lozzio. 1975. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood. 45:321.
16. Keating, A., P.J. Martin, I. D. Bernstein, T. Papayannopoulou, W. Raskind, and J. W. Singer. 1983. EM-2 and EM-3: two new Ph1+ myeloid cell lines. In Normal and Neoplastic Hematopoiesis. D. W. Golde and Paul A. Marks, editors. Alan R. Liss, Inc., New York. 513-520.
17. Kubonishi, I., and I. Miyoshi. 1983. Establishment of a Ph’-chromosome positive cell line from chronic myelogenous leukemia in blast crisis. Int. J. Cell Cloning. 1:105.
18. Pegoraro, L., L. Matera, J. Ritz, A. Levis, A. Palumbo, and G. Biagini. 1983. Establishment of a Ph’-positive human cell line (BV173). J Natl. Cancer Inst. 70:447.
19. Minowada, J., T. Tsubuta, M. F. Greaves, and T. R. Walters. 1977. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens. J. Natl. Cancer Inst. 59:83.
20. Liibbert, M., C.W. Miller, and H. P. Koeffler. 1986. p53 expression in chronic myelogenous leukemia. Blood.68:249a. (Abstr.)
21. Nitta, M., Y. Kato, A. Strife, M. Wachter, J. Fried, A. Perez, S. Jhanwar, R. Duigou-Osterndorf, R. S. K. Chaganti, and B. Clarkson. 1985. Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Blood. 66:1053.
22. Klein, G., J. Zeuthen, I. Erikkson, P. Terasaki, M. Bernoco, A. Rosen, G. Masucci, S. Povey, and R. Ber. 1980. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt’s lymphoma line (P3HR-1). J. Natl. Cancer Inst. 64:725.
23. Klein, G., J. Zeuthen, R. Ber, and I. Ernberg. 1982. Human lymphoma/lymphoma-hybrids. II. Epstein-Barr virus induction patterns. J. Natl. Cancer Inst. 68:197.
24. Koeffler, H. P., R. S. Sparkes, R. Billing, and G. Klein. 1981. Somatic cell hybrid analyses of hematopoietic differentiation. Blood. 58:1160.
25. Collins, S. J., R. C. Gallo, and R. E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (Lond.). 270:347.
26. Glaser, R., M. Nonoyama, M. Whiteman, and T. Forcino. 1979. Studies on an epithelial/Burkitt hybrid cell line with one EBV genome equivalent per cell. Virology. 98:272.
27. Koeffler, H. P., and D. W. Golde. 1978. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science (Wash. DC). 200:1153.
28. Koeffler, H. P., I. S. Y. Chen, and D. W. Golde. 1984. Characterization of a novel HTLV-infected cell line. Blood. 64:482.
29. Boyum, A. 1968. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. Scand.J. Clin. Lab. Invest. 21(Suppl. 97):51.
30. Harlow, E., L. V. Crawford, D. C. Pirn, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:861.
31. Kraus, J. P., and L. E. Rosenberg. 1982. Purification of low-abundancy messenger RNAs from rat liver by polysome immunoadsorption. Proc. Natl. Acad. Sci. USA. 79:4015.
32. Harlow, E., N. M. Williamson, R. Ralsoton, D. M. Helfman, and T. E. Adams. 1985. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol. Cell. Biol. 5:1601.
33. Lamb, P., and L. Crawford. 1986. Characterization of the human p53 gene. Mol. Cell. Biol. 6:1379.
34. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044.
35. Alitalo, K., M. Schwab, C. C. Lin, H. E. Varmus, and J. M. Bishop. 1983. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc. Natl. Acad. Sci. USA. 80:1707.
36. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. J. Mol. Biol. 98:680.
37. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 545 pp.
38. Hardy, K. J., B. M. Peterlin, R. E. Atchison, and J. D. Stobo. 1985. Regulation of expression of the human interferon λ gene. Proc. Natl. Acad. Sci. USA. 82:8173.
39. Feinberg, A. P., and B. Vogelstein. 1982. A technique for radiolabeling DNA restriction endonuclease fragments to high specificity. Anal. Biochem. 132:6.
40. Sompayrac, L., and K. Danna. 1981. Efficient infection of monkey cells with DNA of SV40. Proc. Natl. Acad. Sci. USA. 78:7575.
41. Pinhasi-Kimhi, O., D. Michalovitz, A. Ben-Zeev, and M. Oren. 1986. Specific interaction between the p53 cellular tumour antigen and major heat shock proteins. Nature (Lond.). 320:182.
42. Gilman, M. Z., R. N. Wilson, and R. A. Weinberg. 1986. Multiple protein-binding sites in the 5' flanking region regulate c-fos expression. Mol. Cell. Biol. 6:4305.
43. Prywes, R., and R. G. Roeder. 1986. Inducible binding of a factor to the c-fos enhancer. Cell. 47:777.
44. Greenberg, M. E., A. L. Hermanowski, and E. B. Ziff. 1986. Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription. Mol. Cell. Biol. 6:1050.
45. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:659.
46. Matlashewski, G., L. Banks, D. Pirn, and L. Crawford. 1986. Analysis of human p53 proteins and mRNA levels in normal and transformed cells. FEBS (Fed. Eur. Biochem. Soc.)Lett. 134:665.
47. Doerfler, W. 1983. DNA methylation and gene activity. Annu. Rev. Biochem. 52:93.
48. Bird, A. 1986. CpG-rich islands and the function of DNA methylation. Nature (Lond.). 321:209.
49. Bird, A., M. Taggart, M. Frommer, O.J. Miller, and D. Macleod, 1985. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell. 40:91.